This article is more than 5 years old. Information may no longer be current.

VIDEO: Plenary session moderator discusses advancements in pluripotent stem cell research

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ORLANDO, Fla. — In this Cardiology Today video exclusive, Gregg C. Fonarow, MD, professor of cardiovascular medicine at the University of California, Los Angeles, discusses how pluripotent stem cells are being used to expand the ability to diagnose and potentially treat CVD.

Fonarow was a moderator on the plenary session presented at the Heart Failure Society of America Scientific Assembly and discusses the future of stem cell “clinical trials in a dish.” This approach may allow physicians to study the cardiac toxicity that may occur with specific drugs in individual blood cells and lead to an advanced understanding of the proper therapeutic response.

According to Fonarow, there are many great clinical implications from this trial, and the research presented could lead to “truly achieving a precision medicine approach for CVD.”